Company Information

  

Address: FIFTH FLOOR, WATERLOO EXCHANGE
WATERLOO ROAD 
City: DUBLIN 
State:  
Zip Code: 4 
Telephone: 353-1-634-7800 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Jazz Pharmaceuticals plc is an international biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing meaningful products that address unmet medical needs. We have a diverse portfolio of products and product candidates, with a focus in the areas of sleep and hematology/oncology. Our lead marketed products are: * Xyrem® (sodium oxybate) oral solution, the only product approved by the U.S. Food and Drug Administration, or FDA, and currently marketed for the treatment of both cataplexy and excessive daytime sleepiness, or EDS, in patients with narcolepsy; * Erwinaze® (asparaginase Erwinia chrysanthemi), a treatment approved in the U.S. and in certain markets in Europe (where it is marketed as Erwinase®) for patients with acute lymphoblastic leukemia, or ALL, who have developed hypersensitivity to E.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/20176.49NA23.96
03/20176.76NA21.47
12/20166.41NA17.01
09/20165.72NA21.24
06/20165.69NA24.83
03/20165.30NA24.63
12/20155.23NA26.88
09/20155.23NA25.39

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity0.24Total Liab/Total Assets0.61
Net Inc/Total Assets0.08Total Liab/Inv Cap0.65
Net Inc/Inv Cap0.09Total Liab/Comm Equity1.76
Pretax Inc/Net Sales0.36Interest Coverage Ratio9.61
Net Inc/Net Sales0.27Curr Debt/Equity0.02
Cash Flow/Net Sales0.40LTD/Equity1.06
SG&A/NetSales0.34Total Debt/Equity1.08
Asset Utilization   Liquidity  
Net Receivables Turnover6.70Quick Ratio2.77
Inventory Turnover3.94Current Ratio2.91
Inventory Day Sales0.01Net Rec/Curr Assets0.31
Net Sales/Work Cap3.03Inv/Curr Assets0.05
Net Sales/PP&E13.84  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 394.39 376.05 396.62 374.18
Cost of Goods Sold 28.67 25.07 33.66 24.31
Selling & Admin Exps 132.33 144.26 127.14 124.37
Operating Income 165.04 136.14 165.50 136.25
Interest Exp 18.29 18.84 19.13 18.50
Pretax Income 141.32 115.83 151.95 116.37
Other Income -5.43 -1.46 4.94 -1.39
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 105.60 86.51 124.28 82.23

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 319.21 407.00 425.96 425.99
Receivables - Total 238.75 243.04 234.24 238.07
Inventories - Total 39.66 37.65 34.05 32.35
Total Current Assets 662.50 752.85 748.07 744.23
Net Property, Plant & Equipment 136.63 119.91 107.49 99.90
Total Assets 4,804.02 4,815.82 4,800.23 4,930.58
Liabilities        
Accounts Payable 205.72 248.09 220.19 195.27
Debt in Current Liabilities 36.09 136.09 36.09 36.09
Total Current Liabilities 250.39 392.77 257.41 232.86
Long-Term Debt 1,635.80 1,739.59 1,993.53 2,147.38
Total Liabilities 2,602.99 2,831.84 2,922.89 3,214.58
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.01 0.01 0.01 0.01
Retained Earnings 690.16 601.52 528.91 315.42
Treasury Stock NA NA NA NA
Total Stockholders' Equity 2,201.03 1,983.99 1,877.34 1,716.00
Total Liabilities and Stockholders' Equity 4,804.02 4,815.82 4,800.23 4,930.58

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities 135.09 164.54 180.70 131.17
Net Cash Provided by Investing Activities -30.15 -3.57 -1.86 -1,529.18
Net Cash Provided by Financing Activities -214.48 -181.67 -172.05 895.23

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/2012585.98288.594.34
12/2013872.42216.313.51
12/20141,172.8858.390.93
12/20151,324.80329.545.23
12/20161,487.97396.836.41
Growth Rates26.238.2910.24

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1736554,96191.46




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.